Search for Genetic Predictors of Lung Cancer

AnVil will use its domain expertise and analysis and visualization services and technologies to explore the NCI gene expression data in order to predict which genes may be specifically associated with lung tumors or normal lung tissue. The findings will provide the NCI with information that will aid the search for new lung cancer targets and therapies. AnVil partners with life sciences, pharmaceutical, biotechnology, and healthcare companies, enabling them to see and interpret multiple data sets in integrated views.

"We're very pleased to continue working with the National Cancer Institute database, from which we were able to derive very strong models for genetic predictors in recent work. We look forward to taking our predictive models to the next level as we continue to help further cancer research by generating more insightful data and analysis of the disease,” said Dr. Richard Gill, president and CEO of AnVil.